Rocket Pharmaceuticals Price Target Cut to $36.00/Share From $39.00 by Canaccord Genuity

Dow JonesMar 3 07:47 ET · Ratings

Rocket Pharmaceuticals Is Maintained at Buy by Canaccord Genuity

Dow JonesMar 3 07:47 ET · Ratings

Express News | Canaccord Genuity Maintains Buy on Rocket Pharmaceuticals, Lowers Price Target to $36

BenzingaMar 3 07:39 ET

Promising Pipeline and Financial Stability Drive Buy Rating for Rocket Pharmaceuticals

TipRanksMar 3 01:49 ET · Ratings

When Will Rocket Pharmaceuticals, Inc. (NASDAQ:RCKT) Turn A Profit?

Yahoo FinanceMar 2 07:01 ET

LifeSci Capital Maintains Rocket Pharmaceuticals(RCKT.US) With Buy Rating, Maintains Target Price $55

Moomoo NewsMar 1 13:31 ET · Ratings

Analysts Are Bullish on Top Healthcare Stocks: BioRestorative Therapies (BRTX), Rocket Pharmaceuticals (RCKT)

TipRanksMar 1 13:00 ET · Ratings

A Quick Look at Today's Ratings for Rocket Pharmaceuticals(RCKT.US), With a Forecast Between $15 to $42

Moomoo NewsMar 1 08:00 ET · Ratings

Rocket Pharmaceuticals Q4 Loss Narrower Than Estimates, Pipeline in Focus

Zacks Feb 28 12:30 ET

Morgan Stanley Reaffirms Their Buy Rating on Rocket Pharmaceuticals (RCKT)

TipRanksFeb 28 09:08 ET · Ratings

A Quick Look at Today's Ratings for Rocket Pharmaceuticals(RCKT.US), With a Forecast Between $32 to $42

Moomoo NewsFeb 28 08:00 ET · Ratings

Rocket Pharmaceuticals Is Maintained at Buy by Needham

Dow JonesFeb 28 07:36 ET · Ratings

Rocket Pharmaceuticals Analyst Ratings

BenzingaFeb 28 07:24 ET · Ratings

Promising Pipeline and Market Opportunities Drive Buy Rating for Rocket Pharmaceuticals

TipRanksFeb 28 06:27 ET

Express News | Rocket Pharmaceuticals Inc : Needham Cuts Target Price to $42 From $52

ReutersFeb 28 06:16 ET

Rocket Pharmaceuticals Executive Makes Significant Stock Sale

TipRanksFeb 27 21:05 ET

Analysts Are Bullish on These Healthcare Stocks: Rocket Pharmaceuticals (RCKT), Janux Therapeutics Inc (JANX)

TipRanksFeb 27 20:40 ET · Ratings

8-K: Rocket Pharmaceuticals Reports Fourth Quarter and Full Year 2024 Financial Results and Highlights Recent Progress

SECFeb 27 16:48 ET · Announcements

Rocket Pharmaceuticals Q4 2024 GAAP EPS $(0.62) Beats $(0.71) Estimate

BenzingaFeb 27 16:34 ET

Express News | Rocket Pharmaceuticals: Expects Cash Resources Sufficient to Fund Operations Into Q3 2026

ReutersFeb 27 16:27 ET